Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN1 | Q05586 | 7/20 | 0.54 |
| ▸ | GRIN2B | Q13224 | 7/20 | 0.54 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.39 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.39 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.39 |
| ▸ | MBOAT4 | Q96T53 | 3/20 | 0.32 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.31 |
| ▸ | SHBG | P04278 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30645499 | 0.80 | GRIN1 (0.58) | GRIN1GRIN2BCDK5CDK5R1NR1I3 | |
| SCHEMBL22018389 | 0.79 | GRIN1 (0.60) | GRIN1GRIN2BCDK5CDK5R1NR1I3 | |
| SCHEMBL6812629 | 0.79 | GRIN1 (0.60) | GRIN1GRIN2BCDK5CDK5R1NR1I3 | |
| SCHEMBL4834976 | 0.79 | GRIN1 (0.56) | GRIN1GRIN2BCDK5CDK5R1NR1I3 | |
| SCHEMBL13007746 | 0.79 | GRIN1 (0.60) | GRIN1GRIN2BCDK5CDK5R1NR1I3 | |
| SCHEMBL4833938 | 0.79 | GRIN1 (0.56) | GRIN1GRIN2BCDK5CDK5R1NR1I3 | |
| SCHEMBL133513 | 0.79 | GRIN1 (0.60) | GRIN1GRIN2BCDK5CDK5R1NR1I3 | |
| SCHEMBL374356 | 0.78 | GRIN1 (0.55) | GRIN1GRIN2BCDK5CDK5R1NR1I3 | |
| SCHEMBL7353210 | 0.78 | GRIN1 (0.55) | GRIN1GRIN2BCDK5CDK5R1NR1I3 | |
| SCHEMBL6853527 | 0.77 | GRIN1 (0.68) | GRIN1GRIN2BCDK5CDK5R1NR1I3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210139530-A1 | STEROID DERIVATIVE REGULATORS, METHOD FOR PREPARING THE SAME, AND USES THEREOF | JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) | 2021-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210139530-A1 | STEROID DERIVATIVE REGULATORS, METHOD FOR PREPARING THE SAME, AND USES THEREOF | GABRD, GABRR1, GABRA1 | GRIN1 98/4885GRIN2B 95/4885CDK5 1096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.